Rajesh Malik

Rajesh Malik is the Chief Medical Officer at G1 Therapeutics and POINT Biopharma as a Board Member. Dr. Malik joined G1 in 2014. In his role as Chief Medical Officer and Senior Vice President, R&D, he leads the company’s clinical development, medical affairs, regulatory affairs, biometrics, translational medicine and preclinical teams. Previously, he served as Chief Medical Officer and management board member at Agennix AG, where he was responsible for research and development. Prior to Agennix AG, he served as Chief Medical Officer at Adherex Technologies, where he directed the company's global regulatory strategy and clinical development programs. Dr. Malik also served in oncology clinical development positions at EMD Pharmaceuticals and Bristol-Myers Squibb. Dr. Malik currently serves on the board of directors of Meryx, Inc.

Dr. Malik received his M.D. from the University of Sheffield Medical School in the UK. He completed his residency at Duke University Medical Center and fellowships at the Children's Hospital of Philadelphia and Duke University Medical Center. During his academic career, he was an assistant professor at the University of Virginia, where he conducted basic science and clinical research in addition to patient care and teaching.

Rajesh Malik is the Chief Medical Officer at G1 Therapeutics, based in United States, North America. With a background in Biotechnology, Rajesh Malik has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.